AnalystsRoy BuchananRoy Buchanan's Stock Forecasts
AnalystsRoy Buchanan
Sectors:
Analyst Ranking
Bottom 2%
#4334 out of 4414 analysts
Average Return
-20.89%
Win Rate
28%7 out of 25
Risk vs Reward
Poor
Good
Roy Buchanan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Pardes Biosciences IncPRDS | +81.51% | $1.19 | $2.16 | 2022-12-12 - 2023-08-30 | Buy |
Pardes Biosciences IncPRDS | +60.00% | $1.35 | $2.16 | 2023-03-14 - 2023-08-30 | Buy |
Dynavax Technologies CorpDVAX | +36.27% | $10.45 | $14.24 | 2022-09-26 - 2023-09-26 | Buy |
Argenx SeARGX | +28.33% | $347.02 | $445.34 | 2023-03-02 - 2023-11-28 | Buy |
Dynavax Technologies CorpDVAX | +28.19% | $10.36 | $13.28 | 2023-02-23 - 2023-11-28 | Buy |
Roy Buchanan Analyst Color
Get additional color on Roy Buchanan's coverage of popular stocks
Roy Buchanan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Enanta Pharmaceuticals IncENTA | 6 | Buy | $23.00 | +136.87% | Maintains | 9 days ago |
Dynavax Technologies CorpDVAX | 5 | Buy | $27.00 | +103.31% | Maintains | a month ago |
Arbutus Biopharma CorpABUS | 3 | Buy | $6.00 | +224.32% | Reiterates | 5 months ago |
Curevac NvCVAC | 4 | Buy | $24.00 | +336.36% | Maintains | 7 months ago |
Pardes Biosciences IncPRDS | 2 | Buy | $5.00 | +131.48% | Maintains | 8 months ago |
Esperion Therapeutics IncESPR | 1 | Buy | $15.00 | +1,129.51% | Reiterates | 9 months ago |
Argenx SeARGX | 2 | Buy | $448.00 | +0.60% | Maintains | 9 months ago |
Cormedix IncCRMD | 1 | Hold | $16.00 | +376.19% | Maintains | 9 months ago |
Ibio IncIBIO | 1 | Buy | $37.50 | N/A | Initiates Coverage On | 2 years ago |
Polypid LtdPYPD | 1 | Buy | $420.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.